Application 219170

Type
ANDA
Sponsor
CAPLIN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001MILRINONE LACTATE IN DEXTROSE 5%MILRINONE LACTATEINJECTABLE;INJECTIONEQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)NoNo
002MILRINONE LACTATE IN DEXTROSE 5%MILRINONE LACTATEINJECTABLE;INJECTIONEQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)NoNo

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-productTrade nameIngredientStrengthDosage form / routeTE codesRLD / RSApproval date
A219170-001MILRINONE LACTATE IN DEXTROSE 5%MILRINONE LACTATEEQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02
A219170-002MILRINONE LACTATE IN DEXTROSE 5%MILRINONE LACTATEEQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-productTE code
A219170-001AP
A219170-002AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
CapturedEditionApplication-productTrade nameStrengthDosage form / routeProduct TE source textRLD / RSApproval dateSource SHA-256
2026-02-19 14:30 UTC2026-02A219170-001MILRINONE LACTATE IN DEXTROSE 5%EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219170-002MILRINONE LACTATE IN DEXTROSE 5%EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219170-001MILRINONE LACTATE IN DEXTROSE 5%EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-0231067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219170-002MILRINONE LACTATE IN DEXTROSE 5%EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-0231067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219170-001MILRINONE LACTATE IN DEXTROSE 5%EQ 20MG BASE/100ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219170-002MILRINONE LACTATE IN DEXTROSE 5%EQ 40MG BASE/200ML (EQ 0.2MG BASE/ML)INJECTABLE / INJECTIONAP2025-09-02a50c72e98297…

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
CapturedEditionApplication-productTE codeOrderSource SHA-256
2026-02-19 14:30 UTC2026-02A219170-001AP1011fe1cb6892…
2026-02-19 14:30 UTC2026-02A219170-002AP1011fe1cb6892…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219170-001AP131067a03dcf5…
2025-12-14 10:44 UTC · 2 captures of this ZIP2025-12A219170-002AP131067a03dcf5…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219170-001AP1a50c72e98297…
2026-07-26 02:55 UTC · 3 captures of this ZIP2026-06A219170-002AP1a50c72e98297…

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Milrinone Lactate in 5% DextroseMILRINONE LACTATE IN 5% DEXTROSECaplin Steriles Limiteda2822b12-0560-49d6-ace5-2377c04425e82026-06-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219170
application number: ANDA219170
Milrinone Lactate in 5% DextroseMILRINONE LACTATE IN 5% DEXTROSESomerset Therapeutics, LLC27a19fc1-5e18-44e1-957d-d90f18dedc542026-03-25Warnings, Adverse reactionsExact identifier
application applno (ANDA): 219170
application number: ANDA219170